Drugs Made In America Acquisition II Corp.
(NASDAQ) DMII
Drugs Made In America Acquisition II Corp. Financials at a Glance
Market Cap
$656.08M
Revenue (TTM)
$0.00
Net Income (TTM)
$4.19M
EPS (TTM)
$0.07
P/E Ratio
153.92
Dividend
$0.00
Beta (Volatility)
0.40 (Low)
Dividend
$0.00
Beta (Volatility)
0.40 (Low)
Price
$10.01
Volume
4,405
Open
$10.01
Price
$10.01
Volume
4,405
Open
$10.01
Previous Close
$10.01
Daily Range
$10.00 - $10.01
52-Week Range
$9.86 - $10.01
Dividend
$0.00
Beta (Volatility)
0.40 (Low)
Price
$10.01
Volume
4,405
Open
$10.01
Previous Close
$10.01
Daily Range
$10.00 - $10.01
52-Week Range
$9.86 - $10.01
DMII News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Drugs Made In America Acquisition II Corp.
Industry
Capital Markets
Sector
FinancialsEmployees
2
CEO
Lynn Darlene Stockwell
Headquarters
Fort Lauderdale, FL 33301, US
DMII Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-0%
Return on Assets
1%
Earnings Yield
0.65%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$656.08M
Shares Outstanding
65.58M
Volume
4.41K
Short Interest
0.00%
Avg. Volume
94.01K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$1.30M
EBITDA
$1.30M
Operating Cash Flow
$1.02M
Capital Expenditure
$0.00
Free Cash Flow
$1.02M
Cash & ST Invst.
$223.00
Total Debt
$0.00
Drugs Made In America Acquisition II Corp. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$656.08M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$4.33M
+10489.1%
EBITDA
$1.05M
-2413.2%
Quarterly Fundamentals
Net Cash
$223.00
N/A
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
0.83%
N/A
Return on Invested Capital
-0.26%
N/A
Free Cash Flow
$690.73K
N/A
Operating Cash Flow
$690.73K
N/A